• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hopes for dengue vaccines within seven years

Shiloh

Editor, Senior Moderator
Source: http://www.rnzi.com/pages/news.php?op=read&id=39134


Hopes for dengue vaccines within seven years

Posted at 07:46 on 14 April, 2008 UTC

An organisation that supports the development of vaccines against dengue fever is predicting they will be available in about five to seven years.

The Pediatric Dengue Vaccine Initiative says it supports seven companies, including three in developing countries, that are close to or are already testing their dengue vaccines on humans.

Last week, it agreed to help Hawaiian company, Hawaii Biotech, to develop a vaccine with a grant of 10 million US dollars.

The organisation?s, Dr Richard Mahoney, says it wants to ensure that the vaccines will be available and affordable, especially to people in developing countries.

?We?re doing that in a number of ways. One of them is to work with a number of companies, so that we can stimulate competition. Also, developing countries? manufacturers have demonstrated their ability to produce vaccines at lower costs, so that?s why we give high priority to working with developing countries? manufacturers.?

Dr Richard Mahoney
 
Back
Top Bottom